The increase in IL-1 expression in BC is usually considered as poor progression, since the expression of IL-1 induces a secondary response by activating the secretion of other inflammatory molecules (cytokines, chemokines), and also by altering the expression of adhesion molecules that have a predominant role in metastasis [144]. The gene discussed is IL1B; the disease is breast cancer.